Playlist

Cultural Evening in Ashgabat Commemorates the 120th Anniversary of Classic Turkmen Writer Nurmyrat Saryhanow

22 May. 07:34

Source

The State Library of the State Cultural Center of Turkmenistan held a solemn literary symposium titled "The Path of Life Begins with a Book" to honor the 120th anniversary of the birth of Nurmyrat Saryhanow, a founding figure of modern Turkmen prose. Organized with the comprehensive participation of the faculty and student body of the Yagshygeldi Kakaev International Oil and Gas University, the educational and cultural event was officially reported on the digital corporate portal of the Ministry of Education of Turkmenistan.

The memorial assembly brought together prominent Turkmen writers, contemporary poets, academic literary critics, and university students based in the capital. Keynote speakers delivered detailed analytical presentations on Saryhanow’s life journey and his monumental impact on shaping 20th-century national literature. Academics highlighted that his narratives, characterized by profound psychological insight and realistic portrayals of traditional Turkmen life, continue to serve as structural cornerstones for the moral and intellectual cultivation of contemporary youth.

Nurmyrat Saryhanow is universally acknowledged as a pioneer who established refined structural frameworks for Turkmen short stories and novellas. His acclaimed literary catalog has achieved global reach, with numerous editions translated into multiple foreign languages over decades. The crown jewel of his artistic legacy remains the classic masterpiece "Shukur Bakhshi," a profound novella that highlights humanism, cultural diplomacy, and the peaceful philosophies of the Turkmen nation through the spiritual power of traditional music. The gathering highlighted the enduring value of his artistic contributions.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌